A detailed history of Seeyond transactions in Abb Vie Inc. stock. As of the latest transaction made, Seeyond holds 28,318 shares of ABBV stock, worth $4.86 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
28,318
Previous 33,021 14.24%
Holding current value
$4.86 Million
Previous $4.43 Million 3.34%
% of portfolio
0.44%
Previous 0.53%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $650,471 - $780,086
-4,703 Reduced 14.24%
28,318 $4.58 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $1.49 Million - $1.71 Million
11,120 Added 50.77%
33,021 $4.43 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $556,122 - $707,013
-4,041 Reduced 15.58%
21,901 $3.35 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $3.55 Million - $4.41 Million
-26,924 Reduced 50.93%
25,942 $4.21 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $1.33 Million - $1.68 Million
-12,334 Reduced 18.92%
52,866 $7.16 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $997,500 - $1.13 Million
-9,375 Reduced 12.57%
65,200 $7.03 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $661,560 - $737,016
-6,288 Reduced 7.78%
74,575 $8.4 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $1.36 Million - $1.5 Million
13,282 Added 19.65%
80,863 $8.75 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $297,973 - $402,296
3,702 Added 5.8%
67,581 $7.24 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $2.52 Million - $2.96 Million
29,311 Added 84.79%
63,879 $5.6 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $1.05 Million - $1.41 Million
14,349 Added 70.97%
34,568 $3.39 Million
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $279,865 - $424,310
-4,339 Reduced 17.67%
20,219 $771,000
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $67,874 - $84,925
-941 Reduced 3.69%
24,558 $2.17 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $126,778 - $152,424
-2,013 Reduced 7.32%
25,499 $1.93 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $318,053 - $406,547
4,841 Added 21.35%
27,512 $2 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $1.41 Million - $1.66 Million
18,274 Added 415.6%
22,671 $1.83 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $342,306 - $422,155
4,397 New
4,397 $405,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Seeyond Portfolio

Follow Seeyond and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seeyond, based on Form 13F filings with the SEC.

News

Stay updated on Seeyond with notifications on news.